Please provide your email address to receive an email when new articles are posted on . You've successfully added to your alerts. You will receive an email when new content is published. Click Here to ...

Credit: Getty Images The GINA 2024 asthma update includes new guidance on medications, monitoring, treatment goals, remission, cough variant asthma, children, and more. The Global Initiative for ...

Approval based on global Phase 3 program in children demonstrating Dupixent significantly reduced exacerbations (by 54% to 65%) and improved lung function (by 4.68% to 5.32%) compared to placebo ...

Long-acting muscarinic antagonists (LAMAs), as add-on therapy to inhaled corticosteroids, improved peak forced expiratory volume in 1 second (FEV1) and reduced exacerbations in children younger than ...

While great strides have been made to ensure children have access to proper asthma care in their home and community, linking those environments to the care that children receive while in school has ...

Sanofi and Regeneron’ s Dupixent approved in Japan for children aged 6 to 11 years with bronchial asthma. Approval based on global phase 3 program in children demonstrating Dupixent significantly ...

A new study shows that internet-delivered cognitive behavioral therapy (ICBT) can effectively reduce asthma-related anxiety ...

Changing High-Risk Asthma in Memphis through Partnerships significantly decreased health care use related to asthma among children. A risk-based program at Le Bonheur Children’s Hospital, Changing ...

Associations between asthma and dementia differed based on the patient’s age and asthma control, according to a study ...

Children with asthma who were insured by Medicaid were significantly less likely to receive specialist care over a 1-year period than children with private insurance, based on claims data from nearly ...